ArticleCancer prevention research (Philadelphia, Pa.)2009

Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Daniel Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.